港股早評:三大指數小幅低開 科技股分化 中資券商股繼續大升
對墨西哥和歐盟徵收30%關税,特朗普已發出25份關税函!港股三大指數小幅低開,恒指跌0.16%,國指跌0.09%,恒生科技指數跌0.15%。盤面上,大型科技股升跌各異,快手、小米、網易、騰訊飄紅,百度、京東跌超1%,阿里巴巴、美團小幅走低;中資券商股繼續上週五強勢行情,國聯民生大升近15%,申萬宏源、光大證券、中信建投、中金公司、中信證券齊升;內房股普遍上升,核電股、高鐵基建股、生物醫藥股、建材水泥股紛紛上升,外賣戰持續升級,茶飲料股走高,茶百道升超3%,古茗、蜜雪集團均上升。另一方面,蘋果概念股、煤炭股、汽車股多數下跌,丘鈦科技跌3.2%,兗煤澳大利亞跌近3%。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.